Copy link
Increase text size
Decrease text size
Link copied

Arizona Care Network diabetes patients to use Solve.Care-Boehringer Ingelheim healthcare blockchain network

Thu, 13 Jun 2019, 06:44 am UTC

Arizona Care Network (ACN), a physician-governed accountable care organization, will soon enable its patients with diabetes to use a healthcare blockchain network to manage their disease and optimize care with their physicians and families.

The Diabetes Care Administration Network, produced by a collaboration between healthcare platform Solve.Care and pharmaceutical leader Boehringer Ingelheim, will implement healthcare blockchain technology to improve the care of 25,000 ACN patients with diabetes, according to the press release.

The network will promote interaction between patients and healthcare providers to address the link between diabetes and cardiovascular diseases, as well as provide evidence-based recommendations to educate patients. It will implement Solve.Care’s blockchain-based Care.Wallets to support patients.

The Diabetes Care Administration Network will help bridge a gap by providing a platform which offers vital information on diabetes and cardiovascular diseases in an easily accessible manner,” Solve.Care CEO Pradeep Goel said.

This is invaluable in the healthcare ecosystem as it allows patients to gain a better understanding of their disease while also coordinating their care needs.

ACN, on the other hand, will offer concierge care management and support care coordinators to boost outcomes for participating patients with diabetes.

The Diabetes Care Administration Network is slated to be launched by the end of this year. Furthermore, the results of the ACN launch will help Solve.Care and Boehringer Ingelheim evaluate expansion opportunities in the United States and globally.

Just recently, blockchain-enabled genome sequencing startup Nebula Genomics has inked its first pharma partnership with Merck KGaA’s EMD Serono to help researchers develop new medicines and access Nebula’s network of anonymized genome data to better understand lung cancer.

<Copyright © TokenPost. All Rights Reserved. >

To leave a comment, please sign in.
More
  • Bitcoin (BTC) $8,640.78 (-0.92%)
  • Ethereum (ETH) $167.05 (-1.38%)
  • XRP (XRP) $0.224600 (+0.84%)
  • Bitcoin Cash (BCH) $344.06 (+0.56%)
  • Bitcoin SV (BSV) $299.66 (-5.51%)
  • Bitcoin (BTC) $8,640.78 (-0.92%)
Jan 22, 2020 (Wednesday)
13:12
Crypto Technicals: Major Cryptocurrency Support Resistance Levels
13:12
Crypto Technicals: Major Cryptocurrency Daily Technical Outlook
13:08
Mastercard, Standard Chartered and others join Singapore’s blockchain-based TradeTrust network to digitize international trade
12:01
Crypto Technicals: BCH/USD finds stiff resistance at 55W EMA at 358.85, break above to propel prices higher
10:48
Crypto Technicals: LTC/USD grinds higher, retraces brief dip below 200H MA
10:47
Square Crypto makes first major project announcement
10:17
Crypto accounting service Cryptio selected for ConsenSys’ Tachyon, reveals plans for 2020
09:08
Binance’s global P2P merchant program goes live
08:54
Huobi Group launches its own crypto brokerage platform
07:40
3 executives including founding team members leave SIX Digital Exchange (SDX)
07:17
Turkish City works on a new cryptocurrency to serve citizens better
06:54
Vodafone quits Facebook’s Libra to focus on own digital payment service M-Pesa
06:54
Crypto Technicals: ETH/USD correction holds above 110-EMA, set to resume upside as bias remains bullish
06:04
Grayscale Bitcoin Trust becomes SEC reporting company
05:42
Crypto Technicals: BTC/USD struggles to extend recovery, 'Death Cross' on hourly charts weighs
05:42
Six central banks team up to explore potential cases for CBDCs
04:46
Australia's APRA wants to supervise digital wallets like Facebook's Calibra
04:26
Didn’t ban cryptocurrencies but ringfenced banks from it, clarifies Reserve Bank Of India
Jan 21, 2020 (Tuesday)
12:25
Brave New Coin announces ‘Twitter Sentiment’ data for bitcoin
11:30
Crypto Technicals: Major Cryptocurrency Support Resistance Levels
Subscribe to the TokenPost newsletter!
Don't show me this again today.
Back to top
Copyright ⓒ TokenPost. All Rights Reserved.
PUBLISHsoft